British Journal of Ophthalmology 2008;92:301
Copyright © 2008 by the BMJ Publishing Group Ltd.
At a glance
Harminder S Dua,
Arun D Singh Editors-in-Chief
| The first 150 words of the full text of this article appear below. |
 |
STROMAL INFLAMMATION IN CHRONIC PHASE OF OCULAR SURFACE DISEASES
|
|---|
Five pathological corneas, two with Stevens–Johnson syndrome (SJS), two with ocular cicatrical pemphigoid (OCP) and one with an alkali burns obtained during lamellar keratoplasty were examined histologically by immunostains and
by quantitative real-time RT–PCR to assess for stromal inflammation. Saito et al observed that number of CD34-positive cells in the stroma was decreased and the expression level of biglycan was increased in all of the pathological corneas. The expression level of MIP1a and MIP1b were also markedly increased in all corneas indicating stromal inflammation in the chronic phase of SJS, OCP and alkali burns.
See pages 10.1136/bjo.2007.127738
|
VEP-BASED ACUITY ASSESSMENT
|
|---|
In an effort to assess visual acuity (VA) estimates generated by visual evoked potentials (VEP), Bach et al subjected 40 normal subjects and 24 patients (with corneal and retinal diseases) to checkerboard stimuli with six check sizes. In normal subjects, the stimuli were optically degraded by frosted occluders. Subjective VA was obtained with . . . [Full text of this article]
Relevant Articles
-
Retinopathy of prematurity in the United States
- E M Lad, T C Nguyen, J M Morton, and D M Moshfeghi
Br. J. Ophthalmol. 2008 92: 320-325.
[Abstract]
[Full Text]
[PDF]
-
Risk factors for retinopathy of prematurity in six neonatal intensive care units in Beijing, China
- Y Chen, X-x Li, H Yin, C Gilbert, J-h Liang, Y-r Jiang, M-w Zhao, and Beijing ROP Survey Group
Br. J. Ophthalmol. 2008 92: 326-330.
[Abstract]
[Full Text]
[PDF]
-
Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study
- G Weigert, S Michels, S Sacu, A Varga, F Prager, W Geitzenauer, and U Schmidt-Erfurth
Br. J. Ophthalmol. 2008 92: 356-360.
[Abstract]
[Full Text]
[PDF]
-
Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy
- D Yorston, L Wickham, S Benson, C Bunce, R Sheard, and D Charteris
Br. J. Ophthalmol. 2008 92: 365-368.
[Abstract]
[Full Text]
[PDF]
-
Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience
- S Frenkel, K Hendler, T Siegal, E Shalom, and J Pe’er
Br. J. Ophthalmol. 2008 92: 383-388.
[Abstract]
[Full Text]
[PDF]
-
Visual evoked potential-based acuity assessment in normal vision, artificially degraded vision, and in patients
- M Bach, J P Maurer, and M E Wolf
Br. J. Ophthalmol. 2008 92: 396-403.
[Abstract]
[Full Text]
[PDF]
-
Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion
- T C Kreutzer, C S Alge, A H Wolf, D Kook, J Burger, R Strauss, C Kunze, C Haritoglou, A Kampik, and S Priglinger
Br. J. Ophthalmol. 2008 92: 351-355.
[Abstract]
[Full Text]
[PDF]
-
Abnormal keratocytes and stromal inflammation in chronic phase of severe ocular surface diseases with stem cell deficiency
- T Saito, K Nishida, H Sugiyama, M Yamato, N Maeda, T Okano, and Y Tano
Br. J. Ophthalmol. 2008 92: 404-410.
[Abstract]
[Full Text]
[PDF]
|
|
